Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
Top 3 Health Care Stocks That May Keep You Up At Night In Q1
Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million